Prospective evaluation of the impact of repeated whole prison testing for hepatitis C

Introduction Chronic hepatitis C virus (HCV) infection is prevalent in prisons. Universal reception HCV testing is recommended, but acceptance can be suboptimal. To detect and treat missed HCV infections, a high-intensity test and treat (HITT) programme was introduced to rapidly test entire prisons....

Full description

Saved in:
Bibliographic Details
Main Authors: Stuart McPherson, Naw April Phaw, Manoj Valappil, Carolyn Miller, Craig Thompson, Francesca McCullough, Caroline Allsop, Kate McQue, Ryan Jelley, Jenna Kerry, Jodi Aldridge, Tony Jefferson, Colin Lawton, Lee Christensen, Aung Min Thant
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:BMJ Open Gastroenterology
Online Access:https://bmjopengastro.bmj.com/content/12/1/e001593.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856702255005696
author Stuart McPherson
Naw April Phaw
Manoj Valappil
Carolyn Miller
Craig Thompson
Francesca McCullough
Caroline Allsop
Kate McQue
Ryan Jelley
Jenna Kerry
Jodi Aldridge
Tony Jefferson
Colin Lawton
Lee Christensen
Aung Min Thant
author_facet Stuart McPherson
Naw April Phaw
Manoj Valappil
Carolyn Miller
Craig Thompson
Francesca McCullough
Caroline Allsop
Kate McQue
Ryan Jelley
Jenna Kerry
Jodi Aldridge
Tony Jefferson
Colin Lawton
Lee Christensen
Aung Min Thant
author_sort Stuart McPherson
collection DOAJ
description Introduction Chronic hepatitis C virus (HCV) infection is prevalent in prisons. Universal reception HCV testing is recommended, but acceptance can be suboptimal. To detect and treat missed HCV infections, a high-intensity test and treat (HITT) programme was introduced to rapidly test entire prisons. It remains unknown whether regular HITTs will be required to maintain prison microelimination. We aimed to assess the outcomes of HITTs conducted in a prison 4 years apart with ongoing reception testing.Methods A prospective observational evaluation of the impact of HITTs was conducted in January 2020 and February 2024 at Low Newton, a female prison. The outcomes of the reception testing were reviewed in the intervening period to determine the number of newly identified HCV infections.Results HITTs were successful in testing almost all residents (305/307) in 2020 and (296/296) in 2024. The number of newly diagnosed HCV individuals fell from 6.6% in 2020 to 0.3% in 2024. One new HCV case was identified in the second HITT. In between the HITTs, 89% of receptions had HCV testing, increasing from 83% in 2020 to 95% in 2023. Overall, 81% (144/178) of active HCV infections received antiviral treatment, and 89% achieved sustained virological response. The proportion of active HCV infections between the HITTs was 7.2% through reception testing.Conclusion A follow-up HITT after 4 years yielded only 0.3% active HCV infection in a high HCV prevalence prison and a reasonably good reception testing and treatment programme. Therefore, resources should be focused on optimising reception testing rather than undertaking repeated HITTs.
format Article
id doaj-art-df0746277d9a49a58feb0373bf3b8521
institution Kabale University
issn 2054-4774
language English
publishDate 2025-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Gastroenterology
spelling doaj-art-df0746277d9a49a58feb0373bf3b85212025-02-12T06:00:12ZengBMJ Publishing GroupBMJ Open Gastroenterology2054-47742025-02-0112110.1136/bmjgast-2024-001593Prospective evaluation of the impact of repeated whole prison testing for hepatitis CStuart McPherson0Naw April Phaw1Manoj Valappil2Carolyn Miller3Craig Thompson4Francesca McCullough5Caroline Allsop6Kate McQue7Ryan Jelley8Jenna Kerry9Jodi Aldridge10Tony Jefferson11Colin Lawton12Lee Christensen13Aung Min Thant146 Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK1 Liver Unit and NIHR Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK4 Department of Microbiology and Virology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK1 Liver Unit and NIHR Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK3 Spectrum Community Health CIC, Wakefield, UK1 Liver Unit and NIHR Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK1 Liver Unit and NIHR Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK1 Liver Unit and NIHR Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK1 Liver Unit and NIHR Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK1 Liver Unit and NIHR Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK3 Spectrum Community Health CIC, Wakefield, UK5 Hepatitis C Trust, Newcastle upon Tyne, UK5 Hepatitis C Trust, Newcastle upon Tyne, UK5 Hepatitis C Trust, Newcastle upon Tyne, UK2 Royal Berkshire NHS Foundation Trust, Reading, UKIntroduction Chronic hepatitis C virus (HCV) infection is prevalent in prisons. Universal reception HCV testing is recommended, but acceptance can be suboptimal. To detect and treat missed HCV infections, a high-intensity test and treat (HITT) programme was introduced to rapidly test entire prisons. It remains unknown whether regular HITTs will be required to maintain prison microelimination. We aimed to assess the outcomes of HITTs conducted in a prison 4 years apart with ongoing reception testing.Methods A prospective observational evaluation of the impact of HITTs was conducted in January 2020 and February 2024 at Low Newton, a female prison. The outcomes of the reception testing were reviewed in the intervening period to determine the number of newly identified HCV infections.Results HITTs were successful in testing almost all residents (305/307) in 2020 and (296/296) in 2024. The number of newly diagnosed HCV individuals fell from 6.6% in 2020 to 0.3% in 2024. One new HCV case was identified in the second HITT. In between the HITTs, 89% of receptions had HCV testing, increasing from 83% in 2020 to 95% in 2023. Overall, 81% (144/178) of active HCV infections received antiviral treatment, and 89% achieved sustained virological response. The proportion of active HCV infections between the HITTs was 7.2% through reception testing.Conclusion A follow-up HITT after 4 years yielded only 0.3% active HCV infection in a high HCV prevalence prison and a reasonably good reception testing and treatment programme. Therefore, resources should be focused on optimising reception testing rather than undertaking repeated HITTs.https://bmjopengastro.bmj.com/content/12/1/e001593.full
spellingShingle Stuart McPherson
Naw April Phaw
Manoj Valappil
Carolyn Miller
Craig Thompson
Francesca McCullough
Caroline Allsop
Kate McQue
Ryan Jelley
Jenna Kerry
Jodi Aldridge
Tony Jefferson
Colin Lawton
Lee Christensen
Aung Min Thant
Prospective evaluation of the impact of repeated whole prison testing for hepatitis C
BMJ Open Gastroenterology
title Prospective evaluation of the impact of repeated whole prison testing for hepatitis C
title_full Prospective evaluation of the impact of repeated whole prison testing for hepatitis C
title_fullStr Prospective evaluation of the impact of repeated whole prison testing for hepatitis C
title_full_unstemmed Prospective evaluation of the impact of repeated whole prison testing for hepatitis C
title_short Prospective evaluation of the impact of repeated whole prison testing for hepatitis C
title_sort prospective evaluation of the impact of repeated whole prison testing for hepatitis c
url https://bmjopengastro.bmj.com/content/12/1/e001593.full
work_keys_str_mv AT stuartmcpherson prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT nawaprilphaw prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT manojvalappil prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT carolynmiller prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT craigthompson prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT francescamccullough prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT carolineallsop prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT katemcque prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT ryanjelley prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT jennakerry prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT jodialdridge prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT tonyjefferson prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT colinlawton prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT leechristensen prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc
AT aungminthant prospectiveevaluationoftheimpactofrepeatedwholeprisontestingforhepatitisc